The dermal filler market was valued at $6.3 billion in 2023, and is projected to reach $16.8 billion by 2033, growing at a CAGR of 10.3% from 2024 to 2033.
Dermal filler is a gel-like substance injected into the skin to restore its volume, smooth out its lines & wrinkles, and enhance the contours of the face. The injection of derma fillers is a non-surgical process which shows instant results and lasts for a few months to years, depending on the type of filler injected. Hyaluronic acid is the most common component of derma fillers used to hydrate and volumize the skin. Apart from synthetic fillers, there is a natural form of derma filler where fat from some other body part of a person is injected into the target body part. This process is known by the term - autologous fat grafting.
Rise in occurrence of ageing symptoms at an early stage is one of the major drivers of the dermal filler market. Moreover, increase in aesthetic awareness among individuals, particular females, due the influence of social media is boosting the demand for dermal fillers. In recent times, biostimulatory fillers are acquiring traction among individuals as they promote the production of natural collagen in the body. These fillers promote the natural regenerative process inside the body, hence are not comparable to chemical fillers.
However, the expenses of administering dermal filler injections are significantly high, which prevent a large population from availing the benefits. In addition, the post-procedure complications and side-effects are highly adverse in some individuals, hence making several individuals reluctant about administering such injections. Despite the chances of side effects, the cases of dermal fillers are increasing every year. The International Society of Aesthetic Plastic Surgery conducted a survey in 2023 to determine the statistics of surgical and non-surgical cosmetic procedures around the globe. According to this survey, named, International Survey on Aesthetic/Cosmetic Procedures, the cases of hyaluronic acid fillers upsurged by 29% in 2023, with maximum derma filler cases occurring in the U.S.
Segment Review
The global dermal filler market is segmented into type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly L lactic acid, and others. By gender, it is bifurcated into male and female. Depending on service provider, it is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the hyaluronic acid (HA) segment generated the largest revenue in the market in 2023.
By gender, the female segment dominated the dermal fillers market in 2023.
Depending on service provider, the hospitals segment was the largest stakeholder in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players operating in the global dermal filler market are Teoxane Laboratories, Cutera Inc, Elan aesthetics Inc, Bioxis pharmaceutical, AbbVie Laboratories, Sinclair Pharma, Sosum Global, Revance Therapeutics, Galderma SA, and Merz Pharma. These players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Dermal filler is a gel-like substance injected into the skin to restore its volume, smooth out its lines & wrinkles, and enhance the contours of the face. The injection of derma fillers is a non-surgical process which shows instant results and lasts for a few months to years, depending on the type of filler injected. Hyaluronic acid is the most common component of derma fillers used to hydrate and volumize the skin. Apart from synthetic fillers, there is a natural form of derma filler where fat from some other body part of a person is injected into the target body part. This process is known by the term - autologous fat grafting.
Rise in occurrence of ageing symptoms at an early stage is one of the major drivers of the dermal filler market. Moreover, increase in aesthetic awareness among individuals, particular females, due the influence of social media is boosting the demand for dermal fillers. In recent times, biostimulatory fillers are acquiring traction among individuals as they promote the production of natural collagen in the body. These fillers promote the natural regenerative process inside the body, hence are not comparable to chemical fillers.
However, the expenses of administering dermal filler injections are significantly high, which prevent a large population from availing the benefits. In addition, the post-procedure complications and side-effects are highly adverse in some individuals, hence making several individuals reluctant about administering such injections. Despite the chances of side effects, the cases of dermal fillers are increasing every year. The International Society of Aesthetic Plastic Surgery conducted a survey in 2023 to determine the statistics of surgical and non-surgical cosmetic procedures around the globe. According to this survey, named, International Survey on Aesthetic/Cosmetic Procedures, the cases of hyaluronic acid fillers upsurged by 29% in 2023, with maximum derma filler cases occurring in the U.S.
Segment Review
The global dermal filler market is segmented into type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly L lactic acid, and others. By gender, it is bifurcated into male and female. Depending on service provider, it is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the hyaluronic acid (HA) segment generated the largest revenue in the market in 2023.
By gender, the female segment dominated the dermal fillers market in 2023.
Depending on service provider, the hospitals segment was the largest stakeholder in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players operating in the global dermal filler market are Teoxane Laboratories, Cutera Inc, Elan aesthetics Inc, Bioxis pharmaceutical, AbbVie Laboratories, Sinclair Pharma, Sosum Global, Revance Therapeutics, Galderma SA, and Merz Pharma. These players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Type
- Hyaluronic acid (HA)
- Age group
- 13 to 39
- 40 to 54
- 55 to 69
- Calcium Hydroxylapatite (CaHA)
- Poly L lactic Acid
- Others
By Gender
- Male
- Female
By Service Provider
- Specialty and Dermatology Clinics
- Hospitals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Teoxane Laboratories
- Cutera Inc
- Elan aesthetics Inc
- Bioxis pharmaceutical
- AbbVie Laboratories
- Sinclair Pharma
- Sosum Global
- Revance Therapeutics
- Galderma SA
- Merz Pharma
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: DERMAL FILLER MARKET, BY TYPE
CHAPTER 5: DERMAL FILLER MARKET, BY GENDER
CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER
CHAPTER 7: DERMAL FILLER MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report, titled, 'Dermal Filler Market,'The global dermal filler market size was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as a gel like substance, which is injected into the face to enhance shallow contours, plump thin lips, remove wrinkles, soften facial creases, and diminish the appearance of the scars. Hyaluronic acid is one of the most common types of dermal filler used among the population. Dermal filler is injected by the healthcare providers around the eyes, mouth, and nose. Dermal filler procedures aim to gain youthful appearance and enhance the facial features.The factors that drive the growth of the global dermal filler market size include an increase in the prevalence of the geriatric population, technological advancements in dermal filler product, and surge in demand for anti-aging treatment. In addition, the rise in number of injectable fillers procedure in the female population, notably contributes toward the growth of the global market. According to the International Society of Aesthetic Plastic Surgery, in 2020, approximately 2.5 million hyaluronic acid procedure is conducted in the female population across the world. As per the same source, in 2020, approximately 1.3 million hyaluronic acid procedure is conducted in population of the age group between 40 to 54 years. This augments the need for dermal filler products among the geriatric population. Furthermore, market players focus on the manufacturing of advanced dermal filler for aesthetic solution. For instance, in February 2022, Merz Aesthetics, a medical aesthetics company announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection to improve moderate to severe loss of jawline contour in adults over the age of 21 years. Moreover, Galderma is a dermatologist and pharmaceutical company, received approval for two aesthetic products. Thus, increase in number of dermal filler industry to manufacture dermal filler products propels the growth of the market.
In addition, in May 2020, the Food & Drug Administration (FDA) announced the approval for Restylane kysse, a new hyaluronic acid (HA) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth. The FDA aims to enhance the availability of dermal filler product and increase the access to a wide range of dermal filler for consumers.
Moreover, rise in development of medical aesthetic industry and improvement in healthcare spending are anticipated to drive the growth of the dermal filler market. For instance, in 2021, McKinsey & Company, conducted a survey to analyze the use of dermal filler among different age group and income population. It was reported that, the population with annual income of more than $100,000 are the active users of dermal filler. In addition, the increase in the number of female population and rise in self-awareness among young population regarding the physical appearance led to the development of innovative technologies in the aesthetic sector, thereby propelling the growth of the market.
Moreover, the increase in the number of licensed medical centers is the key factor that boosts the growth of the dermal filler market analysis. The reason behind the increasing number of medical centers is attributed to surge in number of non-invasive aesthetic procedures such as dermal filler and botox. Furthermore, the rise in prevalence of skin damage and increase in geriatric female population, who are more vulnerable to wrinkle and facial line, propel the growth of the market. In addition, the rise in disposable income and increase in awareness regarding different facial aesthetic treatments among the female population fuel the dermal filler market trends.
The dermal filler market share is segmented on the basis of type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. The hyaluronic acid segment dominated the market in 2021, and this trend is expected to continue during the dermal filler market forecast period, owing to increase in number of hyaluronic acids-based dermal filler products, advancement in R&D activities in medical aesthetic industry, and rise in prevalence of early aging of the skin.
By gender, it is bifurcated into male and female. The female segment acquired the top position in the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in demand for dermal filler procedures, rapidly growing emphasis on personal aesthetics among females, and rise in number of female populations conducting minimal invasive aesthetic procedure.
As per service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The hospitals segment led the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in number of hospitals to conduct dermal filler procedures and rise in expenditure by governments to improve the healthcare industry.
North America accounted for a majority of the global dermal filler market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to a rise in prevalence of early aging of the skin due to external environmental factors, increase in the number of approvals for dermal filler product, the presence of dermal filler industry, and development in technology for dermal filler in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of approvals for aesthetic products, the rise in geriatric populations, growth in health care expenditures, and a rise in adoption of dermal filler product.
The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global dermal filler market. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Non-essential surgical procedures were cancelled due to the pandemic. Dermal filler procedures are non-emergency procedures that significantly hampered revenue of aesthetic companies. In addition, sudden, sharp cut in a monthly income of the population is anticipated to have a negative impact on the dermal filler market.
Key Findings of The Study
By type, the hyaluronic acid segment was the highest contributor to the market in 2021.By gender, the male segment was the highest contributor to the market in 2021.
By service provider, the hospitals segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
Companies Mentioned
Key Market Players in the Dermal Filler Market include:- Teoxane Laboratories
- Cutera Inc
- Elan aesthetics Inc
- Bioxis pharmaceutical
- AbbVie Laboratories
- Sinclair Pharma
- Sosum Global
- Revance Therapeutics
- Galderma SA
- Merz Pharma
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 280 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 6.3 billion |
| Forecasted Market Value ( USD | $ 16.8 billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
